JONES CHRISTY sold 13.1% of their position (2K shares) of BETA BIONICS, INC. on the open market
Open‑market sale worth $19.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/26/2026ACC: 0002048467-26-000003
+14.97K
Net shares
Net buyer
$19.9K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
16.96K acquired · 2K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−2K
Price / share
$9.95
Trade value
$19.88K
% of position
13.1%
5/21/2026
15.24K→13.25K
Common Stock
Direct
Shares
+16.96K
Price / share
—
Trade value
—
% of position
128.1%
5/21/2026
13.25K→30.21K
Total
Net shares
+14.97K
Net value
-$19.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/21/2026 | S · Sale | −2K | $9.95 | $19.88K | 13.1% | 15.24K | 13.25K |
| Common Stock Direct | 5/21/2026 | A · Award | +16.96K | — | — | 128.1% | 13.25K | 30.21K |
| Total | +14.97K | -$19.88K | ||||||
Derivative Transactions0
No derivative transactions reported